Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:19 AM
Ignite Modification Date:
2025-12-25 @ 2:19 AM
NCT ID:
NCT01367834
Eligibility Criteria:
Inclusion Criteria:
* Diagnosis of Turner syndrome
* Less than the 50th percentile for length for the general female population
Exclusion Criteria:
* Prior Growth Hormone (GH) therapy
* Diabetes
* Allergy to metacresol (a preservative in the GH liquid that is injected)
* Contraindications for Magnetic Resonance Imaging (MRI) (such as metal in the body)
* Part of a Y chromosome in child's karyotype
* Parent/guardian is not willing for child to be randomized to be in the treatment group (receives Growth Hormone injections for one year) or the control group (receives no Growth Hormone during the study)
* Parent/guardian is not willing for child to have some of her developmental testing digitally recorded for scoring
Healthy Volunteers:
False
Sex:
FEMALE
Minimum Age:
11 Months
Maximum Age:
13 Months
Study:
NCT01367834
Study Brief:
Protocol Section:
NCT01367834